Repository logo
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
Repository logo
    Communities & Collections
    Research Outputs
    Fundings & Projects
    People
    Organizations
    Statistics
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
  1. Home
  2. Chung Shan Medical University
  3. Pure學術人才庫轉入
  4. Clinical significance of circulating IL-10 and fibronectin levels in hepatocellular carcinoma patients with HBV infection
 
  • Details
Options

Clinical significance of circulating IL-10 and fibronectin levels in hepatocellular carcinoma patients with HBV infection

Journal
BioMedicine (Taiwan)
Date Issued
2012-09-01
Author(s)
CHUN-CHE LIN  
DOI
10.1016/j.biomed.2012.06.003
URI
https://www.scopus.com/pages/publications/84866496838
https://scholars.csmu.edu.tw/handle/123456789/32025
Abstract
Background/Introduction: Hepatocellular carcinoma (HCC) is the major cause of cancer-related death in Taiwan and is strongly associated hepatitis B virus (HBV) infections. Previous studies observed an imbalanced T-helper (Th)1/Th2 cytokine profile in HCC patients, however, less attention has been paid to the variation of Th2 cytokines, anti-inflammatory cytokines such as IL-4 and IL-10, in HCC patients. Increased expression of Fibronectin, VEGF and TGF-β1 in HCC patients has been observed, the relationship between these factors and other biomarkers remains unknown. Purpose: This study examined the clinical significance of circulating interleukin-10 and fibronectin levels in HBV-infected hepatocellular carcinoma (HCC) patients. Methods: HCC patients were classified according to international tumor-node-metastasis staging system as I (n = 8), II (n = 24), III (n = 20) and IV (n = 10). Thirty healthy subjects were included as control group. Results: Compared with the control group, 7 test cytokines [interleukin (IL)-1, IL-2, IL-4, IL-6, IL-10, interferon-γ and tumor necrosis factor (TNF)-α] were significantly higher in HCC patients (p < 0.05). Plasma TNF-α concentration in HCC patients increased from stage to stage (p < 0.05), while concentrations of both IL-4 and IL-10 decreased from Stage II to Stage IV (p < 0.05). HCC patients also had significantly higher plasma levels of VEGF, TGF-β1 and fibronectin than the control group (p < 0.05). Within HCC groups, both vascular endothelial growth factor (VEGF) and fibronectin levels decreased in Stage IV. VEGF, transforming growth factor-β1 (TGF-β1) or fibronectin were negatively correlated with IL-10, and the correlation coefficients were lower than e0.7. Both VEGF and TGF-β1 were positively correlated with fibronectin, and the correlation coefficients were higher than 0.7. Conclusion: The circulating levels of IL-10 and fibronectin may reflect progression of HCC. Thus, monitoring these biomarkers may benefit HCC progression evaluation.
Type
journal article
Make it your own

DSpace-CRIS can be extensively configured to meet your needs. Decide which information need to be collected and available with fine-grained security. Start updating the theme to match your Institution's web identity.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback